Skip to main content


Media Coverage

GSK Backed By Fed. Circ. In Leukemia Drug Patent Suit

16 April 2013
Intellectual Property partner Lisa Ferri (New York) is quoted on the Federal Circuit decision that ruled GlaxoSmithKline LLC's leukemia drug Arzerra® does not infringe a Biogen Idec Inc. and Genentech Inc. patent covering an antibody therapy.

Related Information

  • Related People
    Brian W. Nolan
    T +1 212 506 2517
    Lisa M. Ferri
    T +1 212 506 2340
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.